GridAI Technologies (GRDX) Other financing activities (2016 - 2024)
GridAI Technologies' (GRDX) quarterly Other financing activities came in at $1.7 million in Q3 2024, down 53.32% YoY from $3.7 million in Q4 2023, and up 4806344.44% on a QoQ basis from $36.0 in Q2 2024.
GridAI Technologies (GRDX) Other financing activities (2016 - 2024) Analysis & Trends
GridAI Technologies (GRDX) has 9 years of Other financing activities data on file, last reported at $1.7 million in Q3 2024.
- Quarterly Other financing activities fell 53.32% year-over-year to $1.7 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$4.2 million (down 131.02% YoY) and the FY2025 annual result came in at $166448.0, changed N/A from the prior year.
- Other financing activities advanced to $1.7 million in Q3 2024, from $36.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $7.6 million in Q4 2022 to a low of -$5.9 million in Q4 2023.
- A 5-year average of $1.0 million and a median of $26741.0 in 2020 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 790489.77% in 2023, down 177.79% in 2023.
- Tracing GRDX's Other financing activities over 5 years: stood at -$5000.0 in 2020, then jumped by 5755.76% to $282788.0 in 2021, then jumped by 2602.8% to $7.6 million in 2022, then sank by 177.79% to -$5.9 million in 2023, then jumped by 129.1% to $1.7 million in 2024.
- The last three Other financing activities figures came in at $1.7 million (Q3 2024), $36.0 (Q2 2024), and $9.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - |
| 10 | GridAI Technologies | 5.93 Mn | 5.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 36.00 |
| Jun 30, 2024 | 36.00 |
| Mar 31, 2024 | 9.00 |
| Mar 31, 2024 | 9.00 |
| Dec 31, 2023 | -5.95 Mn |
| Dec 31, 2023 | -5.95 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 301.00 |
| Mar 31, 2023 | 301.00 |
| Dec 31, 2022 | 7.64 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | -469.00 |
| Sep 30, 2022 | -469.00 |
| Mar 31, 2022 | 48,482.00 |
| Mar 31, 2022 | 48,482.00 |